Current Edition

Current Features

Why Pharmaceutical Drug Research Needs to Switch Focus

My father had Alzheimer’s. As a journalist and editor, he’d worked with words all his life and had always been impeccably correct about his grammar. But soon after h...
Continue Reading →

Leading Alzheimer's Disease scientist joins NeuroCog Trials

Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease (AD) research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice...
Continue Reading →